Bios Capital Management, LP Lantern Pharma Inc. Transaction History
Bios Capital Management, LP
- $72.6 Billion
- Q2 2025
A detailed history of Bios Capital Management, LP transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 1,075,952 shares of LTRN stock, worth $4.79 Million. This represents 4.68% of its overall portfolio holdings.
Number of Shares
1,075,952
Previous 1,207,709
10.91%
Holding current value
$4.79 Million
Previous $4.28 Billion
20.47%
% of portfolio
4.68%
Previous 5.4%
Shares
2 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.22MCall Options Held
16.4KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA364KShares$1.62 Million0.0% of portfolio
-
Cm Management, LLC200KShares$890,0000.65% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$408,9140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny90.6KShares$403,1700.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA56.5KShares$251,4560.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $48.2M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...